Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats

Full text
Author(s):
da Silva, Joyce T. [1, 2] ; Evangelista, Bianca G. [1] ; Venega, Rafael A. G. [1] ; Seminowicz, David A. [2] ; Chacur, Marucia [1]
Total Authors: 5
Affiliation:
[1] Univ Sao Paulo, Inst Biomed Sci 3, Dept Anat, Sao Paulo - Brazil
[2] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Room 8404, 650 W Baltimore St, Baltimore, MD 21201 - USA
Total Affiliations: 2
Document type: Journal article
Source: Behavioural Pharmacology; v. 30, n. 1, p. 79-88, FEB 2019.
Web of Science Citations: 0
Abstract

Neuropathic pain is driven by abnormal peripheral and central processing, and treatments are insufficiently effective. Antibodies against nerve growth factor (anti-NGF) have been investigated as a potent analgesic treatment for numerous conditions. However, the peripheral and brain effects of anti-NGF in neuropathic pain remain unknown. We examined the effectiveness of anti-NGF in reducing chronic pain by local administration in a rat model of sciatic constriction injury (CCI). NGF and substance P in the dorsal root ganglion (DRG) and spinal cord were evaluated. Neuronal activation was measured using c-Fos in the anterior cingulate cortex and ventrolateral periaqueductal gray. At 14 days after CCI, anti-NGF promoted a significant dose-dependent improvement in mechanical threshold, thermal withdrawal latency, and cold sensitivity, lasting for 5 h. NGF upregulation in the DRG and spinal cord after CCI was decreased by anti-NGF, while substance P was increased only in the DRG, and the treatment reduced it. Anti-NGF induced a significant reduction of neuronal activation in the anterior cingulate cortex, but not in the ventrolateral periaqueductal gray. This study provides the first evidence of the anti-NGF effects on brain activity. Thus, our findings suggest that anti-NGF improves chronic neuropathic pain, acting directly on peripheral sensitization and indirectly on central sensitization. Copyright (c) 2018 Wolters Kluwer Health, Inc. All rights reserved. (AU)

FAPESP's process: 12/24408-6 - Magnetic resonance and supraspinal neuronal activation in chronic neuropathic pain model in rats
Grantee:Joyce Teixeira da Silva
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)